查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1607167

基因擴增市場：按技術、按產品、按樣本類型、按最終用戶 - 2025-2030 年全球預測

Gene Amplification Technologies Market by Technology, Product, Sample Type, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年基因擴增市場估值為267.5億美元，預計到2024年將達到279.1億美元，複合年成長率為4.41%，到2030年將達到362億美元。

基因擴增是指用於增加特定 DNA 序列拷貝數的技術，這對於分子診斷、研究和治療應用至關重要。這些技術包括聚合酵素鏈鎖反應(PCR)、定量 PCR (qPCR) 和次世代定序(NGS) 等技術，主要應用於醫療保健、生物技術和農業領域。基因擴增的需求在於能夠準確檢測和定量微量 DNA 和 RNA，從而促進早期疾病診斷、個人化醫療和先進生物技術研究。其應用範圍從涉及感染疾病和遺傳疾病檢測的臨床診斷到基因組研究和藥物開發的研究場所。最終用戶包括醫院、研究機構、製藥公司和尋求基因改良作物的農業公司。

主要市場統計
基準年[2023] 267.5億美元
預計年份 [2024] 279.1億美元
預測年份 [2030] 362億美元
複合年成長率（%） 4.41%

這一市場成長主要是由基因組學和個人化醫療的進步、生物技術研究投資的增加以及大流行期間對高效診斷技術的需求不斷成長所推動的。數位 PCR 等創新帶來了關鍵的商機，它可以提供精確的定量，並將適用性擴展到癌症液態切片等新興領域。此外，生物技術公司和研究機構之間的合作正在加速創新和產品開發。然而，先進技術的高成本、嚴格的監管要求以及基因操縱的倫理問題等挑戰可能會阻礙市場成長。為了解決這些問題，我們必須努力透過技術進步來降低成本，並簡化監管途徑以加快產品核可。

創新領域包括開發更準確、更快速的擴增技術、提供強大的資料分析能力以及整合人工智慧以增強資料解釋。他們還應該尋找靈活、可擴展的平台，以滿足從大規模篩檢到客製化診斷解決方案的各種需求。基因擴增市場充滿活力，持續的研究和競爭推動成長。專注於個人化腫瘤治療和環境永續農業基因組學等新應用的公司可能會獲得顯著的競爭優勢。

市場動態：揭示快速發展的基因擴增市場的關鍵市場洞察

供需的動態交互作用正在改變基因擴增市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 先進 DNA 擴增技術的顯著擴展
    • 基因組學和分子診斷領域的持續研究和開發活動
    • 慢性病個人化藥物的需求不斷成長
  • 市場限制因素
    • 技術日益複雜，PCR 設備高成本
  • 市場機會
    • 下一代基因擴增技術簡介
    • 細胞和基因治療的新進展
  • 市場挑戰
    • 缺乏技術精湛、經驗豐富的專業人員

波特五力：駕馭基因擴增市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解基因擴增市場的外部影響

外部宏觀環境因素在塑造基因擴增市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解基因擴增市場的競爭狀況

對基因擴增市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣基因擴增市場廠商績效評估

FPNV定位矩陣是評估基因擴增市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製基因擴增市場的成功之路

基因擴增市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開發：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 先進 DNA 擴增技術的顯著擴展
      • 基因組學和分子診斷領域的持續研究和開發活動
      • 慢性病個人化藥物需求不斷成長
    • 抑制因素
      • PCR設備技術複雜、高成本
    • 機會
      • 下一代基因擴增技術簡介
      • 細胞和基因治療的新進展
    • 任務
      • 缺乏技術精湛、經驗豐富的專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章基因擴增市場：依技術分類

  • 恒溫環型核酸擴增
  • 基於核酸序列的擴增
  • 基於 PCR 的擴增
  • 反轉錄
  • 滾環放大

第7章基因擴增市場：依產品

  • 器材與設備
  • 試劑/耗材
  • 軟體和服務

第8章依樣本類型分類的基因擴增市場

  • 血
  • 細胞株
  • 環境
  • 病原
  • 組織

第9章基因擴增市場：依最終用戶分類

  • 合約調查機構
  • 法醫學研究所
  • 醫院和診斷中心
  • 製藥公司
  • 調查機構

第10章 北美和南美基因擴增市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區基因擴增市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲基因擴增市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 4basebio AG
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Ambion Inc.
  • Bayer Pharmaceutics AG
  • Becton Dickinson and Co.
  • Bio-Rad Laboratories
  • bioMerieux SA
  • Cepheid
  • Danaher Corporation
  • Digene Corporation
  • F. Hoffmann-La Roche Ltd.
  • Genentech, Inc.
  • Illumina Inc.
  • LGC Group
  • Menarini Silicon Biosystems SpA
  • Merck KGaA
  • MyBioSource, Inc.
  • Nanjing Vazyme Biotech Co.,Ltd.
  • New England Biolabs, Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • Qiagen NV
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-FF012EDC38AB

The Gene Amplification Technologies Market was valued at USD 26.75 billion in 2023, expected to reach USD 27.91 billion in 2024, and is projected to grow at a CAGR of 4.41%, to USD 36.20 billion by 2030.

Gene amplification technologies refer to techniques used to increase the number of copies of a specific DNA sequence, essential for applications in molecular diagnostics, research, and therapeutics. These technologies encompass methods like polymerase chain reaction (PCR), quantitative PCR (qPCR), and next-generation sequencing (NGS), primarily serving the healthcare, biotechnology, and agriculture sectors. The necessity of gene amplification lies in its ability to accurately detect and quantify minute amounts of DNA or RNA, facilitating early disease diagnosis, personalized medicine, and advanced biotechnological research. Applications are extensive, ranging from clinical diagnostics, which involves detecting infectious diseases and genetic disorders, to research settings for genomic studies and drug development. End-users include hospitals, research institutions, pharmaceutical companies, and agricultural firms seeking crop genetic improvement.

KEY MARKET STATISTICS
Base Year [2023] USD 26.75 billion
Estimated Year [2024] USD 27.91 billion
Forecast Year [2030] USD 36.20 billion
CAGR (%) 4.41%

Growth in this market is primarily driven by advances in genomics and personalized medicine, increased investment in biotechnology research, and rising demand for efficient diagnostic techniques during pandemics. Key opportunities arise from technological innovations like digital PCR, which offers precise quantification, expanding the application potential to emerging fields like cancer liquid biopsies. Additionally, collaborations between biotechnology firms and research institutions can accelerate innovation and product development. However, challenges such as high costs of advanced technologies, stringent regulatory requirements, and ethical concerns regarding genetic manipulation may hinder market growth. Addressing these involves efforts to reduce costs through technological advances and streamline regulatory pathways for faster product approvals.

Innovation areas include developing more precise and rapid amplification technologies that offer robust data analysis capabilities and integrating artificial intelligence to enhance data interpretation. Businesses should also explore flexible and scalable platforms that cater to various needs, from large-scale screenings to bespoke diagnostic solutions. The gene amplification market is dynamic, with continuous research and competition driving growth. Companies opting to focus on emerging applications like personalized oncology treatments or environmentally sustainable agrigenomics are likely to achieve significant competitive advantage.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Amplification Technologies Market

The Gene Amplification Technologies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Significant expansion of advanced DNA multiplication technologies
    • Ongoing R&D activities for genomics and molecular diagnostics arena
    • Growing need for the personalized medicines for chronic conditions
  • Market Restraints
    • Technology complications and high cost of PCR instruments
  • Market Opportunities
    • Introduction of next-generation technologies for gene amplification
    • Emerging developments in cell and gene therapies
  • Market Challenges
    • Lack of skilled and experienced subject experts

Porter's Five Forces: A Strategic Tool for Navigating the Gene Amplification Technologies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Amplification Technologies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Amplification Technologies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Amplification Technologies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Amplification Technologies Market

A detailed market share analysis in the Gene Amplification Technologies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Amplification Technologies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Amplification Technologies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gene Amplification Technologies Market

A strategic analysis of the Gene Amplification Technologies Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gene Amplification Technologies Market, highlighting leading vendors and their innovative profiles. These include 4basebio AG, Abbott Laboratories, Agilent Technologies, Inc., Ambion Inc., Bayer Pharmaceutics AG, Becton Dickinson and Co., Bio-Rad Laboratories, bioMerieux SA, Cepheid, Danaher Corporation, Digene Corporation, F. Hoffmann-La Roche Ltd., Genentech, Inc., Illumina Inc., LGC Group, Menarini Silicon Biosystems SpA, Merck KGaA, MyBioSource, Inc., Nanjing Vazyme Biotech Co.,Ltd., New England Biolabs, Inc., PerkinElmer Inc., Promega Corporation, Qiagen N.V., Takara Bio Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Gene Amplification Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Loop-mediated Isothermal Amplification, Nucleic Acid Sequence Based Amplification, PCR-based Amplification, Reverse Transcription, and Rolling Circle Amplification.
  • Based on Product, market is studied across Instruments & Equipment, Reagents & Consumables, and Software & Services.
  • Based on Sample Type, market is studied across Blood, Cell Lines, Environmental, Pathogen, and Tissue.
  • Based on End-User, market is studied across Contract Research Organizations, Forensic Labs, Hospitals & Diagnostic Centers, Pharmaceutical Companies, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant expansion of advanced DNA multiplication technologies
      • 5.1.1.2. Ongoing R&D activities for genomics and molecular diagnostics arena
      • 5.1.1.3. Growing need for the personalized medicines for chronic conditions
    • 5.1.2. Restraints
      • 5.1.2.1. Technology complications and high cost of PCR instruments
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of next-generation technologies for gene amplification
      • 5.1.3.2. Emerging developments in cell and gene therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled and experienced subject experts
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Gene Amplification Technologies Market, by Technology

  • 6.1. Introduction
  • 6.2. Loop-mediated Isothermal Amplification
  • 6.3. Nucleic Acid Sequence Based Amplification
  • 6.4. PCR-based Amplification
  • 6.5. Reverse Transcription
  • 6.6. Rolling Circle Amplification

7. Gene Amplification Technologies Market, by Product

  • 7.1. Introduction
  • 7.2. Instruments & Equipment
  • 7.3. Reagents & Consumables
  • 7.4. Software & Services

8. Gene Amplification Technologies Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Blood
  • 8.3. Cell Lines
  • 8.4. Environmental
  • 8.5. Pathogen
  • 8.6. Tissue

9. Gene Amplification Technologies Market, by End-User

  • 9.1. Introduction
  • 9.2. Contract Research Organizations
  • 9.3. Forensic Labs
  • 9.4. Hospitals & Diagnostic Centers
  • 9.5. Pharmaceutical Companies
  • 9.6. Research Institutes

10. Americas Gene Amplification Technologies Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Gene Amplification Technologies Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Gene Amplification Technologies Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 4basebio AG
  • 2. Abbott Laboratories
  • 3. Agilent Technologies, Inc.
  • 4. Ambion Inc.
  • 5. Bayer Pharmaceutics AG
  • 6. Becton Dickinson and Co.
  • 7. Bio-Rad Laboratories
  • 8. bioMerieux SA
  • 9. Cepheid
  • 10. Danaher Corporation
  • 11. Digene Corporation
  • 12. F. Hoffmann-La Roche Ltd.
  • 13. Genentech, Inc.
  • 14. Illumina Inc.
  • 15. LGC Group
  • 16. Menarini Silicon Biosystems SpA
  • 17. Merck KGaA
  • 18. MyBioSource, Inc.
  • 19. Nanjing Vazyme Biotech Co.,Ltd.
  • 20. New England Biolabs, Inc.
  • 21. PerkinElmer Inc.
  • 22. Promega Corporation
  • 23. Qiagen N.V.
  • 24. Takara Bio Inc.
  • 25. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GENE AMPLIFICATION TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 2. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. GENE AMPLIFICATION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. GENE AMPLIFICATION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENE AMPLIFICATION TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENE AMPLIFICATION TECHNOLOGIES MARKET DYNAMICS
  • TABLE 7. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY LOOP-MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY NUCLEIC ACID SEQUENCE BASED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PCR-BASED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ENVIRONMENTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PATHOGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TISSUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY FORENSIC LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. GENE AMPLIFICATION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 198. GENE AMPLIFICATION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023